You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

Adult Kidney Disease: Patients on Erythropoiesis-Stimulating Agent-Hemoglobin Level > 12.0 g/dL

Percentage of calendar months within a 12-month period during which a Hemoglobin is measured for patients aged 18 years and older with a diagnosis of advanced CKD (stage 4 or 5, not receiving RRT) or ESRD (who are on hemodialysis or peritoneal dialysis) who are also receiving ESA therapy and have a Hemoglobin Level > 12.0 g/dL

Date Reviewed: November 23, 2013

Measure Info

NQF 1666NQF Endorsement Removed
Measure Type: 
Outcome
Measure Steward: 
Renal Physicians Association
Clinical Topic Area: 
Chronic Kidney Disease

Care Setting: 
Home Care
Outpatient
Post-Acute Care
Data Source: 
Claims
Electronic Health Records
Registry

ACP does not support NQF 1668: “Laboratory Testing (Lipid Profile).” The ACP guideline states that there is inconclusive evidence for periodic monitoring (i.e. lipid profile) in patients diagnosed with stage 1-3 CKD.